Enfermedades neurodegenerativas: desarrollo de terapias
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Sagredo O, García-Arencibia M, de Lago E, Finetti S, Decio A, Fernández-Ruiz J.
Cannabinoids and neuroprotection in basal ganglia disorders
MOLECULAR NEUROBIOLOGY . 36(1): 82-91. Nº de citas: 71
-
García-Arencibia M, González S, de Lago E, Ramos JA, Mechoulam R, Fernández-Ruiz J.
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties
BRAIN RESEARCH . 1134(1): 162-170. Nº de citas: 206
-
GÓMEZ CAÑAS, MARÍA, FERNÁNDEZ RUIZ, JOSÉ JAVIER.
Synthesis and pharmacological evaluation of new (E)- and (Z)-3-aryl-4-styryl-1H-pyrazoles as potential cannabinoid ligands
Arkivoc . 2010: 226-247.
-
Gonzalo-Consuegra C, Santos-García I, García-Toscano L, Martín-Baquero R, Rodríguez-Cueto C, Wittwer MB, Dzygiel P, Grether U, de Lago E, Fernández-Ruiz J.
Involvement of CB(1) and CB(2) receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice.
BIOMEDICINE & PHARMACOTHERAPY . 174: 116473-116473.